Document Details

PerfectStatistics2519

Uploaded by PerfectStatistics2519

Holmes Community College

Tags

cancer health oncology adult health

Summary

This presentation details the various aspects of cancer, from its definition and risk factors to different treatment modalities and support strategies for patients. It covers topics like prevention, diagnosis through tests, and addressing complications like anemia and tumor lysis syndrome. It also touches on emotional support strategies for patients and caregivers.

Full Transcript

CANCER  Abnormal, unrestricted cell division that invades and crowds out healthy tissue  Nondiscriminatory  2nd leading cause of death in U.S.  Higher incidence among African Americans DEFINITION  Smoking and smokeless tobacco, e-cigarettes  Diet high in fat and low in fiber...

CANCER  Abnormal, unrestricted cell division that invades and crowds out healthy tissue  Nondiscriminatory  2nd leading cause of death in U.S.  Higher incidence among African Americans DEFINITION  Smoking and smokeless tobacco, e-cigarettes  Diet high in fat and low in fiber and inadequate nutrients  Obesity and inactivity  Ultraviolent radiation  Environmental and chemical carcinogens  Frequent heavy consumption of alcohol  Genetics RISK FACTORS/CARCINOGENS  Malignant  Benign  Usually rapid growth  Slow growth  Metastasizes  Localized  Outside capsule  Encapsulated  Irregular, more  Smooth, well-defined immovable edges, movable  Little resemblance to  Resembles parent tissue parent tissue  Crowds tissue  Invades tissue  Rarely reoccurs after  May recur removal  Fatal without treatment  Rarely fatal COMPARISON OF NEOPLASMS  Diffusion to other body cavities  Circulation vis blood or lymphatic system THE SPREAD OF CANCER METASTASIS  Carcinoma  Most common type  Arises out of epithelial tissue—solid form  Sarcoma  Solid form—arises out of connective tissue  Less common  Blood forming—leukemias  Lymphoid—Hodgkin’s; non-Hodgkin’s; multiple myeloma FORMS OF CANCER  Dietary  Lifestyle modifications PRIMARY PREVENTION  SBE  Clinical breast exam  Mammograms  Digital rectal exams  Pap Smear  Stop smoking  Prostate exam and/or PSA  Self skin examination SECONDARY PREVENTION  Grade  Stage ◦ GX—normal tissue  Stage 0: Cancer in situ ◦ G1—well-differentiated;  Stage 1: Tumor limited minimal deviation to tissues of origin; ◦ G2—Mod. Differentiated; localized structural changes  Stage 2: Limited local ◦ G3—poorly differentiated; spread extensive structural  Stage 3: Extensive local changes and regional spread ◦ G4—no resemblance to  Stage 4: Metastasis parent tissue CLASSIFICATION OF MALIGNANCIES  C– a change in bowel or bladder habits  A– a sore that does not heal  U– unusual bleeding or discharge  T– thickening or lump  I– indigestion or difficulty in swallowing  O– obvious change in wart or mole  N– nagging cough or hoarseness  White patches on tongue or inside mouth WARNING SIGNS OF CANCER  Pap smear  Biopsy  Bronchoscopy  EGD/colonoscopy/flexible sigmoidoscopy  Mammograms  GI series—UGI, BE  CT scans  PET Scan DIAGNOSTIC/SCREENING TESTS  MRI  Ultrasounds  Radioisotope studies  Lab  CEA—found in rectal/colon cancer  CA-125—elevated in ovarian cancer  PSA/acid phosphatase—prostate  CA-19-9 for pancreatic or hepatobiliary cancer  Occult blood test DIAGNOSTIC/SCREENING TESTS  Often primary  May be preventative, curative, palliative, or diagnostic  Laser, cryosurgery newest surgical techniques TREATMENT--SURGERY  Damages DNA and disrupts cell division and function of mainly cancer cells and occasionally normal cells around that site.  Can be a stand alone treatment or used as an adjunct therapy TREATMENT--RADIATION  External Beam  Patient not radioactive  Ink marks the sites—do not wash away  Sites not to be irradiated are shielded with lead  Side effects  Radiation sickness—NV, diaphoresis  Stomatitis, skin atrophy, changes in pigmentation  Alopecia, chronic dermatitis  Cystitis  Bone marrow depression  Pneumonitis TREATMENT—RADIATION-- TYPES  External Radiation  Nursing interventions  Bathe only according to procedure guidelines  No ointments, lotions, etc. on treated area  Avoid extreme heat or cold  Wear protective clothing  Hi-calorie; hi-protein diet  Increase fluids to 3000 ml/day  Antiemetics and antidiarrheals as indicated  Planned exercise with rest periods  Monitor for infection TREATMENT—RADIATION-- TYPES  Sealed Internal Radiation  Implants in close proximity to cancer for several days  Implant is main source of radioactivity  Types  Vaginal/uterus—head and chest low 45 degrees  Do not bathe below waist or change linens if possible  TED hose  ROM  VS q 4  I&O  Rash  Catheter placed  Encourage dietary intake; 3000 mL fluid  Check applicator q 4 hours  Health care providers wear lead apron and lead gloves  Wear dosimeter film badge to monitor exposure TREATMENT—RADIATION-- TYPES  Unsealed Internal Radiation  Patient is source of radioactivity  Radioactive isotope is given orally or by IV  Nursing interventions  Disposable utensils/trays  Visitor limits  Distance, time, shielding  Gloves when handling body fluids  Diversional activities  Flush toilet several times TREATMENT—RADIATION-- TYPES  Uses  Cure  Control  Or palliate  Act systemically  Affects malignant and healthy cells—especially those of GI system.  Chemo Brain TREATMENT—CHEMOTHERAPY  Can cause leukopenia  If neutrophils < 500 need reverse isolation or protective precautions  Stomatitis – white plaques, lesions, ulcers  Soft toothbrush  Skin - rashes  TCDB  Thrombocytopenia  Alopecia  NVD  Assess for s/s infection  T >100.4, chills  Neutropenia  condition characterized by abnormally low blood levels of infection-fighting neutrophils, a specific kind of white blood cell. Neutropenia increases the risk of bacterial and fungal infections. The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy.  Some s/s: Fever, sore throat, cough, redness, swelling, etc  Treatment: colony stimulating factors (SQ or IV)  Filgrastim, lenograstim, pegfilgrastim  Nursing interventions  Prevent infection, promote nutrition, prevent skin breakdown, promote hygiene, promote oral hygiene CANCER  Hemoglobin levels below 10 are considered anemia  Plenty of rest is required  Plan activities with lots of rest  Epoetin alfa (Epogen, Procrit)  May require packed RBCs ANEMIA WITH CHEMOTHERAPY  Oncologic emergency with rapid lysis of malignant cells  Result of chemotherapy usually but can be with radiation  24 hours to 7 days after treatment  Causes  Hyperkalemia  Hyperphosphatemia  Hyperuricemia  Secondary  Hypocalcemia  Causes increased risk for renal failure and cardiac issues.  Manifestation include: N/V, anorexia, diarrhea, muscle weakness, cramping.  Late s/s tetany, paresthesia, seizures, anuria, cardiac arrest. TUMOR LYSIS SYNDROME  Nursing Interventions  24-48 hours prior to treatment have the client begin hydrating  Allopurinol before and during chemo to keep urine alkaline  Discuss medications containing phosphorus, potassium with provider  Monitor lab TUMOR LYSIS SYNDROME  Uses immunotherapy, human growth factors, and biologic response modifiers  Types  Interferons—can exert antitumor effect by activating a variety of responses.  Interleukins—help coordinate the inflammatory and immune responses of the body, particularly the lymphocyte.  Tumor Necrosis factor—produced by WBC; kills tumor by necrosis without harming healthy cells  Colony stimulating factors—hematopoietic factors that stimulate the growth of young blood cells in marrow—G-CSF—granulocytes; Epoeitin—RBCs, filgrastim TREATMENT—TARGETED THERAPY/BIOTHERAPY  Uses  Cancers of blood-forming and lymphatic tissues and advance or resistant solid tumors  Replacing diseased or damaged bone marrow  Types  Autologous—patient’s own marrow  Allogenic—compatible tissue from donor or sibling  Syngeneic—identical twins  Related  Unrelated TREATMENT—BONE MARROW TRANSPLANT  Pre-transplant treatment  Chemo and/or radiation  Germ free environment  Infusion of stem cells via central line; can take up to 4 hours  Recovery is shorter with peripheral transplant  May experience rejection (allogenic sources only)—skin rash and peeling, NVD, liver dysfunction, photophobia, dry/burning eyes TREATMENT—BONE MARROW TRANSPLANTATION  Know patient’s understanding  Anxiety and depression very common  May see illness as punishment  May react with anger  Goes through stages of grieving  Encourage expression of feelings/emotions  Support groups  Stress progress and events of the day rather than referring to the future optimistically  Be aware of nonverbal communication EMOTIONAL SUPPORT  Want to return to as normal activities as possible as soon as possible  Encourage independence as long as possible  Refer to and encourage participation in self- help groups REHAB  Review ATI AMS cancer chapters

Use Quizgecko on...
Browser
Browser